Related Experiment Video
Updated: Apr 7, 2026

Harnessing the Power of MicroRNA Cargoes in Small Extracellular Vesicles Released from Fresh-Frozen Human Brain Sections
Published on: November 8, 2024
Small Extracellular Vesicles from Neural Cells: Physiological and Pathological Roles, and Potential in
Muhammad Waqas Salim1, Wei Zhang1, Lyndsey Collins-Praino2
1School of Natural Sciences, Macquarie University, Sydney, New South Wales, Australia.
Neural cell-derived small extracellular vesicles (sEVs) show promise for treating neurodegenerative diseases (NDDs). These sEVs can be engineered for enhanced brain delivery and therapeutic efficacy, overcoming challenges in CNS drug delivery.
Area of Science:
- Neuroscience
- Nanomedicine
- Biotechnology
Background:
- Small extracellular vesicles (sEVs) are key in central nervous system (CNS) communication.
- sEVs play dual roles in neurodegenerative diseases (NDDs), both in pathogenesis and potential treatment.
- Neural cell-derived sEVs may offer advantages over stem cell-derived sEVs for brain targeting and therapeutic applications.
Purpose of the Study:
- To review the roles of neural cell-derived sEVs in CNS homeostasis and neurodegenerative disease pathogenesis.
- To analyze the therapeutic potential of neural cell-derived sEVs for treating NDDs like Alzheimer's and Parkinson's disease.
- To discuss engineering strategies for enhancing sEVs for CNS drug delivery and identify translational challenges.
Main Methods:
- Comprehensive literature review of studies on neural cell-derived sEVs.
- Analysis of sEV cargo, barrier traversal mechanisms, and engineering strategies.
- Critical evaluation of current knowledge and translational challenges.
Main Results:
- Neural cell-derived sEVs have specific cargo profiles relevant to brain function and disease.
- Mechanisms for crossing blood-brain and blood-cerebrospinal fluid barriers are being elucidated.
- Engineering approaches can improve sEV targeting, loading, and therapeutic performance.
Conclusions:
- Neural cell-derived sEVs represent a promising, biologically informed platform for neuro-nanomedicine.
- Further research and overcoming translational hurdles are crucial for clinical application in NDDs.
- sEVs engineered from neural cells hold significant potential for advancing NDD treatment.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Fusion of Secretory Vesicles with the Plasma Membrane
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Neural Regulation

